Cartilage mechanical tests: Evolution of current standards for cartilage repair and tissue engineering. A literature review.

Cartilage Tissue Engineering Compression Constitutive Modeling Indentation Standards

Journal

Clinical biomechanics (Bristol, Avon)
ISSN: 1879-1271
Titre abrégé: Clin Biomech (Bristol, Avon)
Pays: England
ID NLM: 8611877

Informations de publication

Date de publication:
08 2019
Historique:
received: 25 05 2018
revised: 07 05 2019
accepted: 10 05 2019
pubmed: 4 6 2019
medline: 2 7 2020
entrez: 4 6 2019
Statut: ppublish

Résumé

Repair procedures and tissue engineering are solutions available in the clinical practice for the treatment of damaged articular cartilage. Regulatory bodies defined the requirements that any products, intended to regenerate cartilage, should have to be applied. In order to verify these requirements, the Food and Drug Administration (FDA, USA) and the International Standard Organization (ISO) indicated some Standard tests, which allow evaluating, in a reproducible way, the performances of scaffolds/treatments for cartilage tissue regeneration. A review of the literature about cartilage mechanical characterization found 394 studies, from 1970 to date. They were classified by material (simulated/animal/human cartilage) and method (theoretical/applied; static/dynamic; standard/non-standard study), and analyzed by nation and year of publication. While Standard methods for cartilage mechanical characterization still refer to studies developed in the eighties, expertise and interest on cartilage mechanics research are evolving continuously and internationally, with studies both in vitro - on human and animal tissues - and in silico, dealing with tissue function and modelling, using static and dynamic loading conditions. there is a consensus on the importance of mechanical characterization that should be considered to evaluate cartilage treatments. Still, relative Standards need to be updated to describe advanced constructs and procedures for cartilage regeneration in a more exhaustive way. The use of the more complex, fibre-reinforced biphasic model, instead of the standard simple biphasic model, to describe cartilage response to loading, and the standardisation of dynamic tests can represent a first step in this direction.

Sections du résumé

BACKGROUND
Repair procedures and tissue engineering are solutions available in the clinical practice for the treatment of damaged articular cartilage. Regulatory bodies defined the requirements that any products, intended to regenerate cartilage, should have to be applied. In order to verify these requirements, the Food and Drug Administration (FDA, USA) and the International Standard Organization (ISO) indicated some Standard tests, which allow evaluating, in a reproducible way, the performances of scaffolds/treatments for cartilage tissue regeneration.
METHODS
A review of the literature about cartilage mechanical characterization found 394 studies, from 1970 to date. They were classified by material (simulated/animal/human cartilage) and method (theoretical/applied; static/dynamic; standard/non-standard study), and analyzed by nation and year of publication.
FINDINGS
While Standard methods for cartilage mechanical characterization still refer to studies developed in the eighties, expertise and interest on cartilage mechanics research are evolving continuously and internationally, with studies both in vitro - on human and animal tissues - and in silico, dealing with tissue function and modelling, using static and dynamic loading conditions.
INTERPRETATION
there is a consensus on the importance of mechanical characterization that should be considered to evaluate cartilage treatments. Still, relative Standards need to be updated to describe advanced constructs and procedures for cartilage regeneration in a more exhaustive way. The use of the more complex, fibre-reinforced biphasic model, instead of the standard simple biphasic model, to describe cartilage response to loading, and the standardisation of dynamic tests can represent a first step in this direction.

Identifiants

pubmed: 31158591
pii: S0268-0033(18)30453-4
doi: 10.1016/j.clinbiomech.2019.05.019
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

58-72

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Gregorio Marchiori (G)

IRCCS Istituto Ortopedico Rizzoli, Laboratory of Biomechanics and Technology Innovation, Via di Barbiano 1/10, 40136 Bologna, Italy. Electronic address: gregorio.marchiori@ior.it.

Matteo Berni (M)

IRCCS Istituto Ortopedico Rizzoli, Laboratory of Biomechanics and Technology Innovation, Via di Barbiano 1/10, 40136 Bologna, Italy.

Marco Boi (M)

IRCCS Istituto Ortopedico Rizzoli, NanoBiotechnology Laboratory (NaBi), Via di Barbiano 1/10, 40136 Bologna, Italy.

Giuseppe Filardo (G)

IRCCS Istituto Ortopedico Rizzoli, NanoBiotechnology Laboratory (NaBi), Via di Barbiano 1/10, 40136 Bologna, Italy; IRCCS Istituto Ortopedico Rizzoli, Applied and Translational Research Center, Via di Barbiano 1/10, 40136 Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH